Director/PDMR Shareholding
18 July 2022
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 15 July 2022, Jeff Popkin, a Non-Executive Director of the Company, bought, in aggregate, 15,208 ordinary shares in the Company at a price of USD 10.45 per ordinary share via the US OTC Markets.
Ends
For further information:
Investor queries
Ann Hyams, Director of Investor Relations I [email protected] I +44 (0)743 582 8138
Media queries
Oliver Winters, Director of Communications I [email protected] I +44 (0)770 332 9024
Nominated Advisor and Joint Broker - Numis Securities
Stuart Dickson I Hugo Rubinstein I +44 (0)20 7260 1000
Joint Broker - Investec Bank plc
David Flin I Alex Wright I +44 (0)20 7597 5970
Financial PR advisers - Finsbury
Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233; Carolina Neri +44 (0)7502 127 516
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | Jeff Popkin | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | Non-Executive Director | ||||||
b) | Initial notification/Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name |
| ||||||
b) | LEI | 2138007AJRLHRVQZLD07 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code |
| ||||||
b) | Nature of the transaction | Acquisition of FQVTF equity via OTC | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information | As above | ||||||
e) | Date of the transaction | 15 July 2022 | ||||||
f) | Place of the transaction | US OTC Market |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.